Nutra Pharma Corp.
NPHC · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $2 | $14 | $8 | $2 |
| - Cash | $0 | $0 | -$0 | -$0 |
| + Debt | $9 | $8 | $5 | $8 |
| Enterprise Value | $11 | $23 | $13 | $11 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 348.4% | 88.3% | -50.3% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 56.8% | 8.7% | 28.7% | 33.3% |
| EBITDA | -$2 | -$13 | -$0 | -$6 |
| % Margin | -430% | -12,827% | -704.6% | -5,988.9% |
| Net Income | $8 | -$13 | -$1 | -$7 |
| % Margin | 1,865.7% | -13,399% | -1,482.1% | -6,314.1% |
| EPS Diluted | 0 | -0.002 | -0 | -0 |
| % Growth | 122.2% | -1,700% | 75% | – |
| Operating Cash Flow | -$1 | -$2 | -$1 | -$1 |
| Capital Expenditures | -$0 | -$0 | -$0 | $0 |
| Free Cash Flow | -$1 | -$2 | -$1 | -$1 |